The REPROCELL Blog

Press Release: ROSLINCT and REPROCELL awarded £1.2 million from Innovate UK for clinical-grade stem cell production

[fa icon="calendar'] Oct 10, 2018 6:35:50 AM / by Simon Padbury posted in Press Release, Research & Development, iPSCs, Stem Cells, Clinical Grade

[fa icon="comment"] 0 Comments

Funding will be used to improve efficiency of induced pluripotent stem cell production

Location: REPROCELL Europe Ltd. (Glasgow, UK) and  RosslinCT (Edinburgh, UK)
Date: October 10, 2018
Continue reading [fa icon="long-arrow-right"]

Join REPROCELL at ISSCR 2018 in Melbourne, Australia

[fa icon="calendar'] Jun 15, 2018 8:07:06 AM / by Robert Annand posted in Stem Cells, ISSCR

[fa icon="comment"] 0 Comments

ISSCR (the International Society for Stem Cell Research) is the preeminent stem cell research group in the world. ISSCR is holding its 2018 Annual Meeting in Melbourne, Australia – and REPROCELL will be there.

Join us 20-23 June at booth 74 and learn how we can help you with your stem cell needs.

Continue reading [fa icon="long-arrow-right"]

REPROCELL's footprint extends to serve life sciences in India

[fa icon="calendar'] Jun 13, 2018 11:07:41 AM / by Rama Modali posted in Stem Cells, Human Tissues, Bioinformatics, Genome Sequencing, Global Expertise

[fa icon="comment"] 0 Comments

REPROCELL India (formerly BioServe Biotechnologies) is a state-of-the-art biotechnology company with a mission to serve the life sciences research ecosystem.

Continue reading [fa icon="long-arrow-right"]

Characterization of iPSCs by Immunocytochemistry

[fa icon="calendar'] Apr 5, 2018 12:20:38 PM / by Zara Puckrin posted in Stem Cells, Drug Discovery

[fa icon="comment"] 0 Comments

As part of our contract services at REPROCELL, we offer induced pluripotent stem cell (iPSC) characterization by immunocytochemistry (ICC). Planning ICC can be tricky, as it requires careful selection of compatible antibodies and fluorochromes. However, if successful, the results are fantastic! Don’t waste valuable research time performing ICC, and let our experts do the work for you!

Continue reading [fa icon="long-arrow-right"]

Five reasons to choose StemRNA 3rd Gen reprogramming

[fa icon="calendar'] Mar 2, 2018 10:07:01 AM / by Anca Haralambie posted in iPSC Reprogramming, Drug Discovery, Stem Cells

[fa icon="comment"] 0 Comments

RNA Reprogramming is used globally for the generation of integration-free induced pluripotent stem cells (iPSCs) by researchers in biotech, academia, research hospitals and government agencies. This reprogramming method is gaining more and more interest and core labs and biotech companies focusing on regenerative medicine and GMP compatibility are adopting this technology and make it their standard.

Continue reading [fa icon="long-arrow-right"]

Cost Effective, Lab-scale iPS Cell Spheroid Culture

[fa icon="calendar'] Feb 9, 2018 10:40:47 AM / by Robert Annand posted in Stem Cells, 3D Cell Culture

[fa icon="comment"] 0 Comments

Many stem cell projects expand to a point where standard culture methods—plates, dishes, flasks, etc.—no longer yield sufficient cells to meet the growing needs for differentiation and regenerative medicine. At this point, larger scale options are required. Traditional bioreactors provide large volume cell culture of liters to hundreds of liters, but they are expensive to buy and expensive to operate. New small scale bioreactors fill the niche between these two extremes perfectly, providing increased cell production over plates or dishes, while being cost-effective to buy and operate.

Continue reading [fa icon="long-arrow-right"]

Xeno-free culture of pluripotent stem cells in NutriStem® hPSC XF medium

[fa icon="calendar'] Feb 5, 2018 5:58:00 AM / by Robert Annand posted in Stem Cells, Human Tissues, Drug Discovery

[fa icon="comment"] 0 Comments

Pluripotent stem cells (PSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are a key component of the growing field of regenerative medicine. Use of culture conditions free of animal products (xeno-free) is essential for PSC projects that are destined for the clinic. NutriStem hPSC XF medium (01-0005) and iMatrix-511 recombinant human laminin-511 E8 fragments (NP8920911) form an ideal system for xeno-free, feeder culture of human PSCs.

 

Check out our NutriStem Midwinter Sale

15% - 35% and more off 500 mL bottles.

Find out more →

Offer expires 15 March 2018. Offer not valid in Asia.

Continue reading [fa icon="long-arrow-right"]